Pitolisant for Excessive Daytime Sleepiness in PWS (2020)

preview_player
Показать описание
In this PWS Clinical Trial highlight, Harmony Biosciences shares information about a new therapeutic: Pitolisant, which was recently approved in the US for the treatment of narcolepsy in adults. Harmony Biosciences is now preparing a Phase 2 study to evaluate the effectiveness of Pitolisant for treating daytime sleepiness in PWS and will be enrolling people with PWS into this study soon.
Рекомендации по теме